MedTrace Logo

Screening To Obviate Preterm Birth

NCT01868308 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 589

Last updated 2017-03-30

No results posted yet for this study

Summary

Our objective is to investigate the predictive value of a panel of biomarkers associated with two biologically plausible pathways of preterm birth: membrane breakdown and cervical remodeling. The investigators will obtain cervical length, cervicovaginal fetal fibronectin, and a panel of novel cervicovaginal biomarkers associated with cervical remodeling in a prospective cohort of symptomatic women with a singleton pregnancy at high risk for preterm birth in an effort to better risk stratify this cohort.

Conditions

  • Preterm Labor
  • Preterm Contractions
  • Abdominal Cramping
  • Back Pain
  • Vaginal Pressure
  • Vaginal Bleeding

Sponsors & Collaborators

Principal Investigators

  • Michal A Elovitz, MD · University of Pennsylvania

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-02-28
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01868308 on ClinicalTrials.gov